...
首页> 外文期刊>Nature Communications >Remodeling of active endothelial enhancers is associated with aberrant gene-regulatory networks in pulmonary arterial hypertension
【24h】

Remodeling of active endothelial enhancers is associated with aberrant gene-regulatory networks in pulmonary arterial hypertension

机译:活性内皮增强剂的重塑与肺动脉高压中的异常基因调节网络有关

获取原文

摘要

Environmental and epigenetic factors often play an important role in polygenic disorders. However, how such factors affect disease-specific tissues at the molecular level remains to be understood. Here, we address this in pulmonary arterial hypertension (PAH). We obtain pulmonary arterial endothelial cells (PAECs) from lungs of patients and controls (n?=?19), and perform chromatin, transcriptomic and interaction profiling. Overall, we observe extensive remodeling at active enhancers in PAH PAECs and identify hundreds of differentially active TFs, yet find very little transcriptomic changes in steady-state. We devise a disease-specific enhancer-gene regulatory network and predict that primed enhancers in PAH PAECs are activated by the differentially active TFs, resulting in an aberrant response to endothelial signals, which could lead to disturbed angiogenesis and endothelial-to-mesenchymal-transition. We validate these predictions for a selection of target genes in PAECs stimulated with TGF-β, VEGF or serotonin. Our study highlights the role of chromatin state and enhancers in disease-relevant cell types of PAH.
机译:环境和表观遗传因素经常在多基因障碍中发挥重要作用。然而,这些因素如何影响分子水平的疾病特异性组织仍有待理解。在这里,我们在肺动脉高压(PAH)中地解决了这一点。从患者的肺部获得肺动脉内皮细胞(PAEC),对照组(n?=α19),并进行染色质,转录组和相互作用分析。总体而言,我们观察PAECS中的活性增强剂的广泛重塑,并识别数百种差异活跃的TFS,但发现稳态的转录组变化很少。我们设计了一种疾病特异性的增强剂 - 基因调节网络,预测PAECS中的引发增强剂由差异有源的TFS激活,导致对内皮信号的异常响应,这可能导致受干扰的血管生成和内皮 - 到间充质转换。我们验证了用TGF-β,VEGF或血清素刺激的PAEC中的靶基因的这些预测。我们的研究突出了染色质状态和增强剂在疾病相关细胞类型PAH中的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号